Proteinuria: How to evaluate an important finding

Cleveland Clinic Journal of Medicine

Volumn 70, Issue 6, 2003, Pages 535-547

  Kashif, Waqar ^a   Siddiqi, Nauman ^a   Dincer, Ayse P ^a   Dincer, H Erhan ^a   Hirsch, Sheldon ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b MICHAEL REESE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NEUTROPHIL CYTOPLASMIC ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; SULFOSALICYLIC ACID;

ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CREATININE CLEARANCE; CREATININE URINE LEVEL; DISEASE EXACERBATION; DISEASE MARKER; EARLY DIAGNOSIS; ECHOGRAPHY; GLOMERULOPATHY; HUMAN; IMMUNOELECTROPHORESIS; KIDNEY BIOPSY; KIDNEY DISEASE; LABORATORY DIAGNOSIS; MICROALBUMINURIA; PATHOPHYSIOLOGY; PROTEIN ELECTROPHORESIS; PROTEINURIA; REVIEW; TURBIDIMETRY; URINALYSIS;

EID: 0038037684     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.70.6.535     Document Type: Review

References (81)

1. Wagner DK, Harris T, Madans JH. Proteinuria as a biomarker: risk of subsequent morbidity and mortality. Environ Res 1994; 66:160-172.
2. Grimm RH, Svendsen KH, Kasiske B, et al. Proteinuria is a risk factor for mortality over 10 years follow up. Kidney Int 1997; 52:10-14.
3. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. BMJ 1990; 300:297-300.
4. Kanwar YS, Liu ZZ, Kashihara N, Wallner EI. Current status of the structural and functional basis of glomerular filtration and proteinuria. Semin Nephrol 1991; 11:390-413.
5. Guasch A, Deen WM, Myers BD. Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans. J Clin Invest 1993; 92:2274-2282.
6. Ghitescu L, Desjardins M, Bendayan M. Immunocytochemical study of glomerular permeability to anionic, neutral and cationic albumins. Kidney Int 1992; 42:25-32.
7. Fujigaki Y, Nagase M, Kobayasi S, Hidaka S, Shimomura M. Intra-GBM site of functional filtration barrier for endogenous proteins in rats. Kidney Int 1993; 43:567-574.
8. Hoyer JR, Seiler MW. Pathophysiology of Tamm-Horsfall protein. Kidney Int 1979; 16:279-289.
9. Zager RA, Cotran RS, Hoyer JR. Pathologic localization of Tamm-Horsfall protein in interstitial deposits in renal disease. Lab Invest 1978; 38:52-57.
10. Cotran RS, Hodson CJ. Extratubular localization of Tamm-Horsfall protein in experimental reflux nephropathy in the pig. In Hodson CJ, Kincaid-Smith P (editors): Reflux Nephropathy. New York: Masson Publishing USA, 1979:13.
11. Gyure WL. Comparison of several methods for semiquantitative determination of urinary protein. Clin Chem 1977; 23:876-879.
12. Carel RS, Silverberg DS, Kamisky R, Aviram A. Routine urine analysis (dipstick) findings in mass screening of healthy adults. Clin Chem 1987; 33:2106-2108.
13. Ralston SH, Caine N, Richards I, O'Reilly D, Sturrock RD, Capell HA. Screening for proteinuria in a rheumatology clinic: comparison of dipstick testing, 24-hour quantitative protein and protein/creatinine ratio in random urine samples. Ann Rheum Dis 1988; 47:759-763.
14. Bernard A, Lauwerys RR. Proteinuria: changes and mechanisms in toxic nephropathies. Toxicology 1991; 21:373-405.
15. James GP, Bee DE, Fuller JB. Proteinuria: accuracy and precision of laboratory diagnosis by dipstick analysis. Clin Chem 1978; 24:1934-1939.
16. Allen JK, Krauss EA, Deeter RG. Dipstick analysis of urinary protein. A comparison of Chemstrip-9 and Multistix-10SG. Arch Pathol Lab Med 1991; 115:34-37.
17. Rose BD. Pathophysiology of Renal Diseases, 2nd ed. New York: McGraw-Hill, 1987:11-16.
18. Carroll MF, Temte JL. Proteinuria in adults: a diagnostic approach. Am Fam Phys 2000; 62:1333-1340.
19. Marcos SK, El-Nahas AM, Brown P, Haylor J. Effect of iodinated water soluble contrast media on urinary protein assays. BMJ 1992; 305:29.
20. Chesley LC. The variability of proteinuria in the hypertensive complications of pregnancy. J Clin Invest 1993; 18:617-629.
21. Lemann J Jr, Doumas BT. Proteinuria in health and disease assessed by measuring the urinary protein/creatinine ratio. Clin Chemistry 1987; 33:297-299.
22. Bennett PH, Haffner S, Kasiske BL, et al. Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. Am J Kidney Dis 1995; 25:107-112.
23. Derhaschnig U, Kittler H, Woisetschlager C, Bur A, Herkner H, Hirschl MM. Microalbumin measurement alone or calculation of the albumin/creatinine ratio for screening of hypertensive patients? Nephrol Dial Transplant 2002; 17:81-85.
24. Keane WF. Proteinuria: its clinical importance and role in progressive renal disease. Am J Kidney Dis 2000; 35:97-105.
25. Abbate M, Remuzzi, G. Proteinuria as a mediator of tubulo-interstitial injury. Kidney BP Res 1999; 22:37-46.
26. Sheerin NS, Sacks SH. Chronic interstitial damage in proteinuria. Does complement mediate tubulointerstitial injury? Kidney BP Res 1999; 22:47-52.
27. Vriesendorp R, Donker AJM, de Zeeuw D. Effects of nonsteroidal anti-inflammatory drugs on proteinuria. Am J Med 1986; 81(suppl 2B):84-93.
28. Mulyadi I, Stevens C, Munro S, Lingard J, Bermingham M. Body fat distribution and total body fat as risk factors for microalbuminuria in the obese. Ann Nutr Metab 2001; 45:67-71.
29. Basdevant A, Cassuto D, Gibault T, Raison J, Guy-Grand B. Microalbuminuria and body fat distribution in obese subjects. Int J Obes Relat Metab Disord 1994; 18:806-811.
30. Metcalf P, Baker J, Scott A, Wild C, Scragg R, Dryson E. Albuminuria in people at least 40 years old: effect of obesity hypertension, and hyperlipidemia. Clin Chem 1992; 38:1802-1808.
31. Solerte SB, Rondanelli M, Giacchero R, et al. Serum glucagon concentration and hyperinsulinaemia influence renal hemodynamics and urinary protein loss in normotensive patients with central obesity. Int J Obes Relat Metab Disord 1999; 23:997-1003.
32. Lokkegaard N, Haupter I, Kristensen TB. Microalbuminuria in obesity. Scand J Urol Nephrol 1992; 26:275-278.
33. Adelman RD, Restaino IG, Alon US, Blowey DL. Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents. J Pediatr 2001; 138:481-485.
34. Kasiske BL, Cleary MP, O'Donnell MP, Keane WF. Effects of genetic obesity on renal structure and function in the Zucker rat. J Lab Clin Med 1985; 106:598-604.
35. Praga M, Hernandez E, Andres A, Leon M, Ruilope LM, Rodicio JL. Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron 1995; 70:35-41.
36. Solerte SB, Fioravanti M, Schifino N, Ferrari E. Effects of diet-therapy on urinary protein excretion albuminuria and renal hemodynamic function in obese diabetic patients with overt nephropathy. Int J Obesity 1989; 13:203-211.
37. Rytand DA, Speiter S. Prognosis in postural (orthostatic) proteinuria: forty to fifty-year follow-up of six patients after diagnosis by Thomas Addis. N Engl J Med 1981; 305:618-621.
38. Springberg PD, Garrett LE Jr, Thompson AL Jr, Collins NF, Lordon RE, Robinson RR. Fixed and reproducible proteinuria: results of a 20-year follow-up study. Ann Intern Med 1982; 97:516-519.
39. Wagner MD, Smith FG, Tinglof BO, et al. Epidemiology of proteinuria: a study in 4807 school children. J Pediatr 1968; 73:825-832.
40. Dodge WF, West EF, Smith EH, et al. Proteinuria and hematuria in school children. Epidemiology and early natural history. J Pediatr 1976; 88:327-347.
41. Von Bonsdorff, M, Koskenvuo K, Salmi HA, Pasternack A. Prevalence and causes of proteinuria in 20-year-old Finnish men. Scand J Urol Nephrol 1981; 15:285-290.
42. Muth RG. Asymptomatic mild intermittent proteinuria. Arch Intern Med 1965; 115:569-574.
43. Sinniah R, Law CH, Pwee HS. Glomerular lesions in patients with asymptomatic persistent and orthostatic proteinuria discovered on routine medical examination. Clin Nephrol 1977; 7:1-14.
44. Carrie BJ, Hilberman M, Schroeder JS, et al. Albuminuria and the permselective properties of the glomerulus in cardiac failure. Kidney Int 1980; 17:507-514.
45. Sklar AH, Chaudhary BA. Reversible proteinuria in obstructive sleep apnea syndrome. Arch Intern Med 1988; 148:87-89.
46. Cameron JS. Membranous nephropathy: the treatment dilemma. Am J Kid Dis 1982; 1:371-375.
47. Cohen AH, Nast CC, Adler SG, et al. The clinical usefulness of kidney biopsies in the diagnosis and management of renal disease [abstract]. Kidney Int 1985; 27:135.
48. Turner MW, Hutchinson TA, Barre PE, et al. A prospective study on the impact of the renal biopsy in clinical management. Clin Nephrol 1986; 26:217-221.
49. Shah RP, Vathsala A, Chiang GS, et al. The impact of percutaneous renal biopsies on clinical management. Ann Acad Med Singapore 1993; 22:908-911.
50. Richards NT, Darby S, Howie AJ, et al. Knowledge of renal histology alters patient management in over 40% of cases. Nephrol Dial Transplant 1994; 9:1255-1259.
51. Hlatky MA. Is renal biopsy necessary in adults with nephrotic syndrome? Lancet 1982; 2:1264-1268.
52. Kassirer JP. Is renal biopsy necessary for optimal management of the idiopathic nephrotic syndrome? Kidney Int 1983; 24:561-575.
53. Richards NT, Darby S, Howie AJ, Adu D, Michael J. Knowledge of renal histology alters patients management in over 40% of cases. Nephrol Dial Transplant 1994; 9:1255-1259.
54. Phillippi PJ, Reynolds J, Yamauch H, et al. Persistent proteinuria in asymptomatic individuals: renal biopsy studies on 50 patients. Mil Med 1966; 131:1311-1317.
55. McLaine PN, Drummond KN, et al. Benign persistent asymptomatic proteinuria in childhood. Pediatrics 1970; 47:548-552.
56. Chen BTM, Ooli BS, Tan KKT, et al. Comparative studies of asymptomatic proteinuria and hematuria. Arch Intern Med 1974; 134:901-905.
57. Yoshikawa N, Uehara S, Yamana K, et al. Clinicopathological correlations of persistent asymptomatic proteinuria in children. Nephron 1980; 25:127-133.
58. Yoshikawa N, Kitagawa K, Ohta K et al. Asymptomatic constant isolated proteinuria in children. J Pediatr 1991; 119:375-379.
59. Eddy AA. Experimental insights into the tubulointerstitial disease accompanying primary glomerular disease. J Am Soc Nephrol 1994; 5:1273-1287.
60. Marso SP, Ellis SG, Gurm HS, Lyde BW, Topol EJ. Proteinuria is a key determinant of death in patients with diabetes after isolated coronary artery bypass grafting. Am Heart J 2000; 139:939-944.
61. Samuelsson O, Wilhelmsen L, Elmfeldt D, et al. Predictors of cardiovascular morbidity in treated hypertension: results from preventive trial in Goteburg, Sweden. J Hypertens 1985; 3:167-176.
62. Ljungman S, Wikstarnd J, Hartford M, Berglund G. Urinary albumin excretion-a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle aged non-diabetic normal and hypertensive men. Am J Hypertens 1996; 9:770-778.
63. Agewall S, Wikstarnd J, Ljungman S, Fagerberg B. Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk factor intervention study group. Am J Cardiol 1997; 80:164-169.
64. Haffner SM, Stern MP, Gruber MK, et al. Microalbuminuria. Potential marker for increased cardiovascular risk factors in non-diabetic subjects. Atherosclerosis 1990; 0:727-731.
65. Woo J, Cockram CS, Swaminathan R, et al. Microalbuminuria and other cardiovascular risk factors in non-diabetic subjects. Int J Cardiol 1992; 37:345-350.
66. Agewall S, Wikstrand J, Ljungman S, Fagerberg B. Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypetensive men with or without diabetes mellitus. Am J Cardiol 1997; 80:164-196.
67. Agewall S, Wikstrand J, Ljungman S, Herlitz H, Fagerberg B. Does microalbuminuria predict cardiovascular events in nondiabetic men with treated HTN? Am J Hypertens 1995; 8:337-342.
68. Pontremoli R, Sofia A, Ravera M, et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension. The MAGIC study. Hypertension 1997; 30:1135-1143.
69. Cirillo M, Stellato D, Laurenzi M, Panarelli W, Zancheti A, De Santo NG. Pulse pressure and isolated systolic hypertension: association with microalbuminuria. Kidney Int 2000; 58:1211-1218.
70. Pedrenelli R, Dell'Omo G, Fenno G, et al. Microalbuminuria and pulse pressure in hypertensive and atherosclerotic men. Hypertension 2000; 35:48-54.
71. Agrawal B, Berger A, Wolf K, Luft FC. Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension. J Hypertens 1996; 14:223-228.
72. Pontremoli R, Nicolella C, Viazzi F, et al. Microalbuminuria is an early marker of target organ damage in essential hypertension. Am J Hypertens 1998; 11:430-438.
73. Bigazzi R, Bianchi S, Baldari D, Baldari G, Campese VM. Increased thickness of carotid artery in patients with essential hypertension and microalbuminuria. J Hum Hypertens 1995; 9:827-833.
74. Gosling P, Hughes EA, Reynolds TM, Fox JP. Microalbuminuria is an early response following acute myocardial infarction. Eur Heart J 1991; 12:508-513.
75. American Diabetes Association. Clinical practice recommendations 1997. Diabetic nephropathy Diabetes Care 1997; 20(suppl 1):24-27.
76. Eastman RC, Keen H. The impact of cardiovascular disease on people with diabetes: the potential for prevention. Lancet 1997; 350:29-32.
77. Guerrero-Romero F, Rodriguez-Moran M. Relationship of microalbuminuria with the diabetic foot ulcers in type II diabetes. J Diab Compl 1998; 12:193-196.
78. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage: the steno-hypothesis. Diabetologia 1989; 32:219-226.
79. Miettinen H, Haffner SM, Lehto S, Ronnemaa T, Pyurala K, Laakso M. Proteinuria predicts stroke and other atherosclerotic vascular disease events in non-diabetic and non-insulin dependent diabetic subjects. Stroke 1996; 27:2033-2039.
80. Knobl P, Schernthaner G, Schnack C, et al. Thrombogenic factors are related to urinary albuminexcretion in type I (insulin dependent) and type II (non-insulin dependent) diabetic patients. Diabetologia 1993; 36:1045-1050.
81. Pedrinelli R, Giampietro O, Carmassi F, et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994; 344:14-18.